A Randomized, Pilot Study Comparing Cost Effectiveness on Two Commercially Available Gastric Feeding Tubes
NCT ID: NCT04030871
Last Updated: 2025-08-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
7 participants
INTERVENTIONAL
2019-10-25
2023-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Percutaneous Endoscopic Gastrostomy Versus Percutaneous Endoscopic Gastrostomy With Jejunal Extension
NCT06717321
Complications Associated With Primary Placement of Gastrostomy for Feeding
NCT05173935
Effectiveness Gastric Balloon in Obese Adolescents
NCT04209842
A Single-center, Feasibility Study to Evaluate the Use and Safety of the Percutaneous Ultrasound Gastrostomy Technique
NCT03575754
Endoscopical Dilation of Benign Esophageal Strictures
NCT01738997
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The most common G-tube used by the OSU Endoscopy Lab is the Balloon Bolus feeding tube. In 2017 the Capsule Dome G-Tube became commercially available. The cost of the Capsule dome g-tube is twice as expensive as the standard balloon g-tube. The insertion costs would be comparable.
The need to perform a pilot comparative study of the two g-tubes is necessary to improve our physicians understanding of the potential cost-effectiveness that longer patency we could gather from the alternative device.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Capsule Dome G-Tube
Capsule Dome G-Tube
Capsule Dome G-Tube
Feeding replacement tubes with two different FDA approved devices in forty subjects
Balloon Bolus feeding tube
Balloon Bolus feeding tube
Balloon Bolus feeding tube
Feeding replacement tubes with two different FDA approved devices in forty subjects
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Capsule Dome G-Tube
Feeding replacement tubes with two different FDA approved devices in forty subjects
Balloon Bolus feeding tube
Feeding replacement tubes with two different FDA approved devices in forty subjects
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Adults (18-75 years of age)
3. Requirement of long term enteral tube feeding (\> to 12 months) and are due for a change of their initial or prior replacement bolus Percutaneous Endoscopic Gastrostomy (PEG) tube.
4. Ability to consent for the procedure and study.
5. Subjects must be able to communicate in english via telephone and understand the assessment checklists.
Exclusion Criteria
1. Enteral feeding is not necessary for at least 12 months,
2. A medical condition that makes it impossible for them to communicate via telephone
3. Subjects requiring feeding into the jejunum via a combined gastroenterostomy-jejunostomy tube
4. Subjects who require endoscopic replacement of their current gastrostomy tube.
5. Impaired cognition, inability to provide assessment feedback by telephone.
6. Subjects not expected to survive \> 12 months
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ohio State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
George Papachristou
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jeffery R Groce, MD
Role: PRINCIPAL_INVESTIGATOR
Ohio State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Endoscopy Doan
Columbus, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
New-41476
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.